Rein Therapeutics Q3 EPS $(0.06) Beats $(0.10) Estimate
Benzinga Newsdesk 4 days ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Rein Therapeutics (NASDAQ:RNTX) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.10) by 40 percent. This is a 71.43 percent increase over losses of $(0.21) per share from
Rein Therapeutics (NASDAQ:RNTX) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.10) by 40 percent. This is a 71.43 percent increase over losses of $(0.21) per share from the same period last year.
